Evidence map›Paper›PMID 29615645›Full record

Trial reportScientific reports2018

Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.

Raquel Iniesta, Karen Hodgson, Daniel Stahl, Karim Malki, Wolfgang Maier, Marcella Rietschel, Ole Mors, Joanna Hauser, Neven Henigsberg, Mojca Zvezdana Dernovsek and 7 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Learning Outcomes That Maximally Differentiate Psychiatric Treatments.International journal of methods in psychiatric research · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Predicting the outcome of psychotherapy for chronic depression by person-specific symptom networks.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Predicting treatment outcome in depression: an introduction into current concepts and challenges.European archives of psychiatry and clinical neuroscience · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 7 countries.

Raquel IniestaBiostatistics and Health Informatics Department. Institute of Psychiatry, Psychology and Neuroscience, Kings College London. 16 De Crespigny Park, London, SE5 8AF, UK.
Karen HodgsonSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Daniel StahlBiostatistics and Health Informatics Department. Institute of Psychiatry, Psychology and Neuroscience, Kings College London. 16 De Crespigny Park, London, SE5 8AF, UK.
Karim MalkiSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Wolfgang MaierDepartment of Psychiatry, University of Bonn, Regina-Pacis-Weg 3, 53113, Bonn, Germany.
Marcella RietschelCentral Institute of Mental Health, Division of Genetic Epidemiology in Psychiatry, Square J5, 68159, Mannheim, Germany.ORCID 0000-0002-5236-6149
Ole MorsResearch Department P, Aarhus University Hospital, Norrebrogade 44, DK-8000, Aarhus C Risskov, Denmark.
Joanna HauserLaboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Collegium Maius, Fredry 10, 61-701, Poznań, Poland.
Neven HenigsbergCroatian Institute for Brain Research, Medical School, University of Zagreb, 10 000, Zagreb, Salata 3, Croatia.
Mojca Zvezdana DernovsekVzgojni zavod Planina, Planina 211, 6232 Planina, Slovenina and Universitiy of Ljubljana, Medical Faculty, Vrazov trg 2, 1000, Ljubljana, Slovenia.
Daniel SoueryLaboratoire de Psychologie Médicale, Université Libre de Bruxelles and Psy Pluriel - Centre Européen de Psychologie Médicale, Av Jack Pastur 47a, 1180, Uccle, Belgium.
Richard DobsonBiostatistics and Health Informatics Department. Institute of Psychiatry, Psychology and Neuroscience, Kings College London. 16 De Crespigny Park, London, SE5 8AF, UK.ORCID 0000-0003-4224-9245
Katherine J AitchisonSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Anne FarmerSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Peter McGuffinSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Cathryn M LewisSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.ORCID 0000-0002-8249-8476
Rudolf UherSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK. uher@dal.ca.
King's College London · GBAarhus University Hospital · DKCentral Institute of Mental Health · DEDalhousie University · CAPoznan University of Medical Sciences · PLUniversité Libre de Bruxelles · BEUniversity of Alberta · CAUniversity of Bonn · DEUniversity of Zagreb · HR

Funding

Department of Health 05/40/04
6 · The paper itself

Abstract

Individuals with depression differ substantially in their response to treatment with antidepressants. Specific predictors explain only a small proportion of these differences. To meaningfully predict who will respond to which antidepressant, it may be necessary to combine multiple biomarkers and clinical variables. Using statistical learning on common genetic variants and clinical information in a training sample of 280 individuals randomly allocated to 12-week treatment with antidepressants escitalopram or nortriptyline, we derived models to predict remission with each antidepressant drug. We tested the reproducibility of each prediction in a validation set of 150 participants not used in model derivation. An elastic net logistic model based on eleven genetic and six clinical variables predicted remission with escitalopram in the validation dataset with area under the curve 0.77 (95%CI; 0.66-0.88; p = 0.004), explaining approximately 30% of variance in who achieves remission. A model derived from 20 genetic variables predicted remission with nortriptyline in the validation dataset with an area under the curve 0.77 (95%CI; 0.65-0.90; p < 0.001), explaining approximately 36% of variance in who achieves remission. The predictive models were antidepressant drug-specific. Validated drug-specific predictions suggest that a relatively small number of genetic and clinical variables can help select treatment between escitalopram and nortriptyline.

Indexed as

AdultAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicBiomarkersCitalopramFemaleHumansMajor Depressive DisorderMaleNortriptylineTreatment OutcomeAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicBiomarkersCitalopramNortriptyline

Identifiers

PMID29615645
PMCPMC5882876
OpenAlexW2805077948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.